VERVE THERAPEUTICS Trademark

Trademark Overview

On Monday, November 18, 2019, a trademark application was filed for VERVE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERVE THERAPEUTICS trademark a serial number of 88696522. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Verve Therapeutics, Inc.. The VERVE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research and development
verve therapeutics

General Information

Serial Number88696522
Word MarkVERVE THERAPEUTICS
Filing DateMonday, November 18, 2019
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6768590
Registration DateTuesday, June 21, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements

Description of MarkThe mark consists of the word "VERVE" centered with the word "THERAPEUTICS" positioned underneath and justified to the right, with overlapping curved lines positioned both above the word "VERVE" and underneath the words "VERVE" and "THERAPEUTICS".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicespharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 23, 2019
Primary Code042
First Use Anywhere DateMonday, September 30, 2019
First Use In Commerce DateMonday, September 30, 2019

Trademark Owner History

Party NameVerve Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215
Party NameVerve Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVerve Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, November 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 16, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 19, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 19, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 12, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 12, 2022FINAL REFUSAL E-MAILED
Tuesday, April 12, 2022SU - FINAL REFUSAL - WRITTEN
Thursday, February 24, 2022ASSIGNED TO EXAMINER
Monday, January 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 10, 2022ASSIGNED TO LIE
Wednesday, January 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2021SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, June 14, 2021USE AMENDMENT FILED
Tuesday, June 22, 2021SOU EXTENSION 1 GRANTED
Monday, June 14, 2021SOU EXTENSION 1 FILED
Monday, June 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 14, 2021TEAS EXTENSION RECEIVED
Monday, June 14, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, January 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION WRITTEN
Friday, February 21, 2020ASSIGNED TO EXAMINER
Tuesday, November 26, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, November 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 21, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics verve development research pharmaceutical